Recent Finacing
Recent Raise
PolyActiva develops the PREZIA covalent drug‑polymer platform for biodegradable implants and injectable gels enabling sustained, site‑specific ocular and intra‑articular delivery, with ocular implant PA5108 in clinical development.
